
About this podcast
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
416 episodes · business
The Readout Loud
About this podcast
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Latest episodeWhy two promising heart drugs flopped and what's next
Recent episodes
- 411: Capricor's data clash and a fugitive in the C-suite30 Jul · 37 min
- 410: A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribing23 Jul · 1 h 04 min
- 409: Predicting biotech clinical trials & a new Alzheimer's drug controversy16 Jul · 36 min
- 408: Whistleblower takes on health insurance and FDA commissioner candidates9 Jul · 44 min
- 407: The mysterious case of Eli Lilly's obesity drug25 Jun · 43 min
- 406: New hope in treating Huntington's disease and a report card on RFK Jr.'s promises18 Jun · 36 min
- 405: An obesity drug deep-dive, and peptides move mainstream11 Jun · 36 min
- 404: What RevMed's pancreatic cancer drug meant for one patient4 Jun · 38 min
- 403: Biotech exec Jeremy Levin on the industry's strategic turning point28 May · 47 min
- 402: Guarding biotech from China and big bets in longevity21 May · 44 min